Community Drug Board, Inc.

Community Drug Board, Inc., doing business as CHC Addiction Services, is a nonprofit organization based in Akron, Ohio, that operates as a federal grant recipient delivering integrated addiction treatment, homelessness prevention, and housing support services to HUD and the Substance Abuse and Mental Health Services Administration (SAMHSA).

CHC Addiction Services acts predominantly as a prime grant recipient (78% of recent awards) and as a sub-recipient on state opioid response and substance-abuse block grant programs. The organization delivers concrete capabilities spanning inpatient opioid treatment, medication-assisted treatment (MAT) with methadone and buprenorphine, intensive outpatient counseling, trauma-informed care for women, integrated primary healthcare, rapid rehousing and permanent supportive housing, peer recovery services, barrier mitigation support, and Homeless Management Information Systems (HMIS) administration. Representative prime grants include a $279,808 Continuum of Care (CoC) Program award from HUD's Assistant Secretary for Community Planning and Development (CFDA 14.267) covering October 1, 2025, through September 30, 2026, focused on permanent supportive housing and rapid rehousing alongside MAT and case management; a $259,367 CoC award for the prior fiscal year; and a $237,163 CoC award for fiscal 2023–2024. CHC has received consecutive HUD CoC grants since at least 2021, establishing continuity in federal homelessness and addiction services delivery.

Customer concentration is narrow and stable. HUD's Assistant Secretary for Community Planning and Development accounts for 60 awards (100% coverage of the top-customer block). SAMHSA contributes 18 awards across two distinct reporting lines. The three-agency customer set reflects the federal funding architecture for addiction treatment and homelessness: HUD CoC programs anchor prime grant work, while SAMHSA sub-awards flow through the Ohio Department of Mental Health under State Opioid Response 4.0 (SOS), State Opioid Response 3.0 (SOS), Substance Abuse Prevention and Treatment Block Grant (SAPT), and related programs. Sub-recipient work includes a February 2026 SOS award, multiple January and October 2025 SOS tranches, and a February 2025 SUPTRS award, all from Ohio Department of Mental Health as the prime. A Kent State University sub-award from October 2024 named CHC as a partner in the SC-MATx project to expand MAT services for an additional 50 opioid use disorder patients, offering office-based opioid treatment and community engagement in underserved populations.

Activity has remained flat to modest — two awards in 2022, seven each in 2023 and 2024, six in 2025, and two through mid-2026. Combined dollars obligated across all awards total $13.7 million. Only two awards face ultimate completion within the next twenty-four months, presenting a low recompete-cliff exposure. The organization does not hold federal contracts or contract vehicles (GWACs, IDIQs, BPAs); all federal work flows through federal and state grant programs, making CHC a grant-dependent entity without prime contract capacity or subcontracting relationships on government procurement vehicles.